<DOC>
	<DOCNO>NCT00908310</DOCNO>
	<brief_summary>This international , multi-center , post-marketing surveillance study patient moderate renal insufficiency administer gadodiamide , Omniscan , MRI . Omniscan administer intravenously medical discretion prescribe physician .</brief_summary>
	<brief_title>Post-marketing Safety Study Patients With Moderate Renal Insufficiency Who Receive Omniscan Contrast-enhanced Magnetic Resonance Imaging ( MRI )</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<criteria>The subject refer clinically indicate MRI examination gadoliniumbased contrast agent . The subject know suspected chronic kidney disease eGFR great equal 30mL &lt; 60 mL/min/1.73 m2 measure within 30 day prior plan index OMNISCAN administration . The subject agree contact followup 24 month . Patients know suspected NSF base biopsy confirmation onset sign symptom NSF last least 7 day follow : 1. skin swelling , harden tightening ; redden darken patch ; burn itching ; 2. eye yellow raise spot white eye ; 3. bone muscle stiffness joint ; difficulty move straighten arm , hand , legs foot ; bone pain especially hips ribs muscle weakness . Patients allergic GBCA . Patients chronic renal disease GFR &lt; 30 mL/min/1.73 m2 measure within 30 day prior plan OMNISCAN administration . Patients acute renal insufficiency severity due hepatorenal syndrome peri operative liver transplantation period .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>CKD - Chronic Kidney Disease</keyword>
	<keyword>GBCA - Gadolinium-based contrast agent</keyword>
	<keyword>GFR - Glomerular Filtration Rate</keyword>
	<keyword>MRI - Magnetic Resonance Imaging</keyword>
	<keyword>NSF - Nephrogenic Systemic Fibrosis</keyword>
	<keyword>Known suspected CKD eGFR great equal 30mL &amp; less 60 mL/min/1.73m2 measure within 30 day prior OMNISCAN .</keyword>
</DOC>